Login or sign up
For business

Adenosine Therapeutics

4.0· 9 reviews
Average ratingGreat
4.0/ 5

Based on 9 reviews

533%
433%
333%
20%
10%
Ask AI

Ask AI about Adenosine Therapeutics

Generated with AI from 9 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Patrick O'Brien
Reviews 1

I have been using the services of Adenosine Therapeutics for quite a while now, and I must say they provide an exceptional experience. The website is easy to navigate and provides detailed information. I am highly satisfied with their products and services. Keep up the good work!

Michael Hinchey
Reviews 1

I have been using Adenosine Therapeutics products for a while now, and I am impressed with their quality and effectiveness. The website provides detailed information about each product, which helps in making an informed decision. I would highly recommend their services!

Jackie Cervantes
Reviews 1

👍 I had an amazing experience with Adenosine Therapeutics! The website is easy to navigate and provides all the necessary information. The team was highly responsive and helped me with all my queries. I am extremely satisfied and would definitely choose them again! 😊

Ian Hardiman
Reviews 1

I recently had the opportunity to use Adenosine Therapeutics services. I was impressed by their professionalism and expertise. The website was informative, and the ordering process was straightforward. I would definitely consider using their services again in the future.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Adenosine Therapeutics

Adenosine Therapeutics (ATL), located in Charlottesville, VA, is a drug discovery and development company that was co-founded in 1999 by University of Virginia (UVa) Professor Joel Linden and entrepreneur Robert Capon (one of three cofounders of Virologic, NASDAQ: VLGC.)

Through an in-license agreement with the University of Virginia Patent Foundation, ATL was granted exclusive, worldwide rights to the University's adenosine-related patent portfolio, including apadenoson, developed as Stedivaze, a cardiac stress agent for use in diagnosis of coronary artery disease. Stedivaze was shepherded by ATL to the end of Phase II development before ATL sold substantially all its assets to Clinical Data, Inc. (CLDA) in 2008. CLDA and its successors carried on development into late Phase III.

Website
adenrx.com
Address
1180 Seminole Trl Ste 495
Categories
Research